Barinthus Biotherapeutics Plc Adr (BRNS)

Apr 01, 2025

BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com UK

Apr 01, 2025

Feb 04, 2025

Dollar General Corp (DG) Shares Up Despite Recent Market Volatility - The News Heater

Feb 04, 2025

Feb 01, 2025

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - MSN

Feb 01, 2025

Jan 31, 2025

Exclusive-Mexico's Pemex, billionaire Slim renegotiate deepwater gas project - Yahoo Finance

Jan 31, 2025

Jan 25, 2025

RBC raises Reckitt Benckiser stock target to £57.00, keeps outperform - MSN

Jan 25, 2025

Jan 14, 2025

Stocks Generating Improved Relative Strength: Revolution Medicines - MSN

Jan 14, 2025

Jan 10, 2025

Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com

Jan 10, 2025

Dec 04, 2024

The big rebrand: Why these 4 biopharmas changed their name this year - PharmaVoice

Dec 04, 2024

Sep 25, 2024

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer

Sep 25, 2024

Sep 03, 2024

Mexico Shingles Vaccine Market Size & Outlook, 2023-2030 - Grand View Research

Sep 03, 2024

Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 21, 2024

Mar 18, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 18, 2024